Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Community driven content discussing all aspects of software development from DevOps to design patterns. Git isn’t hard to learn. Moreover, with a Git GUI such as Atlassian’s Sourcetree, and a SaaS ...

CGM technology could become a cornerstone in modern diabetes management. Credit: Halfpoint via Shutterstock. In an advancement for diabetes management, the US Food and Drug Administration (FDA) has ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...

Medtronic received Food and Drug Administration clearance for its new InPen smart insulin pen app that can recommend corrections for missed or inaccurate insulin doses at mealtime. The authorization ...

GALWAY, Ireland - Medtronic has received clearance from the U.S. Food and Drug Administration for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

GALWAY, Ireland - Medtronic plc (NYSE: NYSE:MDT), a global healthcare technology company, has received U.S. Food and Drug Administration (FDA) clearance for its InPen™ app, which features missed meal ...

The InPen with Simplera CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received FDA clearance for its new InPen insulin delivery system application. The app features ...